Mindell J, Boaz A, Joffe M, Curtis S, Birley M
London Health Observatory, UK.
J Epidemiol Community Health. 2004 Jul;58(7):546-51. doi: 10.1136/jech.2003.012401.
Health impact assessment differs from other purposes for which evidence is collated in a number of ways, including:the focus on complex interventions or policy and their diverse effects on determinants of health;the need for evidence on the reversibility of adverse factors damaging to health;the diversity of the evidence in terms of relevant disciplines, study designs, quality criteria and sources of information;the broad range of stakeholders involved;the short timescale and limited resources generally available;the pragmatic need to inform decision makers regardless of the quality of the evidence. These have implications for commissioning and conducting reviews. Methods must be developed to: facilitate comprehensive searching across a broad range of disciplines and information sources; collate appropriate quality criteria to assess a range of study designs; synthesise different kinds of evidence; and facilitate timely stakeholder involvement. Good practice standards for reviews are needed to reduce the risk of poor quality recommendations. Advice to decision makers must make explicit limitations resulting from absent, conflicting, or poor quality evidence.
健康影响评估在许多方面不同于为其他目的而整理证据,包括:关注复杂干预措施或政策及其对健康决定因素的多样影响;需要有关损害健康的不利因素可逆性的证据;证据在相关学科、研究设计、质量标准和信息来源方面的多样性;涉及的利益相关者范围广泛;通常时间尺度短且可用资源有限;无论证据质量如何,向决策者提供信息的实际需求。这些对委托和开展综述有影响。必须制定方法以:促进跨广泛学科和信息来源进行全面检索;整理适当的质量标准以评估一系列研究设计;综合不同类型的证据;并促进利益相关者及时参与。需要综述的良好实践标准以降低质量不佳建议的风险。向决策者提供的建议必须明确因证据缺失、相互矛盾或质量不佳而产生的局限性。